Mergers & Acquisitions
CSL
Communications advisor for various acquisitions and proposals including:
US $275 million purchase of the Novartis
Talecris Biotherapeutics
US $925 million acquisition of Aventis Behring
$108 million Zenyth Therapeutics acquisition
Disposal of CSL Animal Health unit to Pfizer
